Published in Neurosci Lett on April 09, 1981
Difference gel electrophoresis: a single gel method for detecting changes in protein extracts. Electrophoresis (1997) 5.06
Nosocomial infection with Rhizopus microsporus in preterm infants: association with wooden tongue depressors. Lancet (1996) 2.62
Gut blood flow velocities in the newborn: effects of patent ductus arteriosus and parenteral indomethacin. Arch Dis Child (1990) 2.59
Volatile compounds produced in sterile fish muscle (Sebastes melanops) by Pseudomonas perolens. Appl Microbiol (1973) 1.73
An outbreak of Bacillus cereus respiratory tract infections on a neonatal unit due to contaminated ventilator circuits. J Hosp Infect (1999) 1.72
Clinical significance of antenatal calyceal dilatation detected by ultrasound. Lancet (1990) 1.64
Ethamsylate reduces the incidence of periventricular haemorrhage in very low birth-weight babies. Lancet (1981) 1.59
Gastro-oesophageal reflux in preterm infants. Arch Dis Child (1989) 1.55
A new class of tyrosine hydroxylase inhibitors and a simple assay of inhibition in vivo. Biochem Pharmacol (1967) 1.54
Long-term effects of multiple doses of methamphetamine on tryptophan hydroxylase and tyrosine hydroxylase activity in rat brain. J Pharmacol Exp Ther (1980) 1.49
Differential effects of stimulants on monoaminergic transporters: pharmacological consequences and implications for neurotoxicity. Eur J Pharmacol (2000) 1.46
Acetaldehyde production by single-strain lactic streptococci. J Dairy Sci (1966) 1.37
Transfer before delivery on Merseyside: an analysis of the first 140 patients. Br J Obstet Gynaecol (1983) 1.33
Role of dopamine in the neurotoxic effects of methamphetamine. J Pharmacol Exp Ther (1985) 1.29
Differential effects of psychostimulants and related agents on dopaminergic and serotonergic transporter function. Eur J Pharmacol (1999) 1.27
Rapid and reversible effects of methamphetamine on dopamine transporters. J Pharmacol Exp Ther (1997) 1.26
Frontal horn thin walled cysts in preterm neonates are benign. Arch Dis Child Fetal Neonatal Ed (2001) 1.22
Identity of additional aroma constituents in milk cultures of Streptococcus Lactis var. Maltigenes. J Dairy Sci (1966) 1.17
Postnatal encephaloclastic porencephaly--a new lesion? Arch Dis Child (1992) 1.17
Influence of methamphetamine on nigral and striatal tyrosine hydroxylase activity and on striatal dopamine levels. Eur J Pharmacol (1976) 1.15
The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) on monoaminergic systems in the rat brain. Eur J Pharmacol (1986) 1.14
The long-term effects of multiple doses of methamphetamine on neostriatal tryptophan hydroxylase, tyrosine hydroxylase, choline acetyltransferase and glutamate decarboxylase activities. Life Sci (1979) 1.14
Klebsiella infection in a neonatal intensive care unit: role of bacteriological surveillance. J Hosp Infect (1984) 1.10
Caffeine or theophylline for neonatal apnoea? Arch Dis Child (1992) 1.09
Gastric emptying in preterm infants. Arch Dis Child Fetal Neonatal Ed (1994) 1.04
Abnormal gut blood flow velocities in neonates at risk of necrotising enterocolitis. J Pediatr Gastroenterol Nutr (1992) 1.03
Methamphetamine-induced rapid decrease in dopamine transporter function: role of dopamine and hyperthermia. J Pharmacol Exp Ther (2000) 1.02
Roles of D1 and D2 dopamine receptor subtypes in mediating the methamphetamine-induced changes in monoamine systems. J Pharmacol Exp Ther (1986) 1.01
Posthaemorrhagic hydrocephalus in newborn term infants. Arch Dis Child (1985) 1.01
Decarboxylation of alpha-keto acids by Streptococcus lactis var. maltigenes. Appl Microbiol (1967) 0.99
Prophylactic ethamsylate for periventricular haemorrhage. Arch Dis Child (1984) 0.99
Does phenobarbitone prevent periventricular hemorrhage in very low-birth-weight babies?: a controlled trial. Pediatrics (1982) 0.97
Effect of methamphetamine on neurotensin concentrations in rat brain regions. J Pharmacol Exp Ther (1987) 0.97
Interaction between hyperthermia and oxygen radical formation in the 5-hydroxytryptaminergic response to a single methamphetamine administration. J Pharmacol Exp Ther (1997) 0.96
Role of the dopamine uptake carrier in the neurochemical response to methamphetamine: effects of amfonelic acid. Eur J Pharmacol (1985) 0.96
The effects of reserpine, alpha-methyltyrosine, and L-3,4-dihydroxyphenylalanine on brain tyrosine transaminase. Proc Natl Acad Sci U S A (1969) 0.96
Endogenous neurotensin antagonizes methamphetamine-enhanced dopaminergic activity. Brain Res (1994) 0.96
Methamphetamine treatment rapidly inhibits serotonin, but not glutamate, transporters in rat brain. Brain Res (1998) 0.96
Gastric emptying and gastro-oesophageal reflux in preterm infants. Arch Dis Child Fetal Neonatal Ed (1996) 0.95
Role of dopamine D-1 and D-2 receptors in the regulation of neurotensin systems of the neostriatum and the nucleus accumbens. Eur J Pharmacol (1989) 0.95
Characterization of methamphetamine effects on the striatal-nigral dynorphin system. Eur J Pharmacol (1988) 0.95
Dopamine D2-receptors regulate neurotensin release from nucleus accumbens and striatum as measured by in vivo microdialysis. Brain Res (1996) 0.95
Acinetobacter meningitis: acquired infection in a neonatal intensive care unit. Arch Dis Child (1982) 0.95
Role of endogenous dopamine in the neurochemical deficits induced by methcathinone. J Pharmacol Exp Ther (1997) 0.94
Immediate and long-term effects of 3,4-methylenedioxymethamphetamine on serotonin pathways in brain of rat. Neuropharmacology (1987) 0.94
Relative contents and concomitant release of prodynorphin/neoendorphin-derived peptides in rat hippocampus. Proc Natl Acad Sci U S A (1983) 0.93
Differences in the central serotonergic effects of methylenedioxymethamphetamine (MDMA) in mice and rats. Neuropharmacology (1987) 0.92
Oxygen radicals diminish dopamine transporter function in rat striatum. Eur J Pharmacol (1997) 0.92
Role of endogenous dopamine in the central serotonergic deficits induced by 3,4-methylenedioxymethamphetamine. J Pharmacol Exp Ther (1988) 0.91
Doppler assessment of human neonatal gut blood flow velocities: postnatal adaptation and response to feeds. J Pediatr Gastroenterol Nutr (1992) 0.91
Does mechanical ventilation precipitate gastro-oesophageal reflux during enteral feeding? Arch Dis Child (1989) 0.91
Effects of cocaine on extrapyramidal and limbic dynorphin systems. J Pharmacol Exp Ther (1990) 0.90
Adrenal and striatal tyrosine hydroxylase activity after methamphetamine. J Pharmacol Exp Ther (1973) 0.90
Influence of dopamine synthesis on methamphetamine-induced changes in striatal and adrenal tyrosine hydroxylase activity. Naunyn Schmiedebergs Arch Pharmacol (1979) 0.89
Cellular catabolism of recombinant tissue-type plasminogen activator. Identification and characterization of a novel high affinity uptake system on rat hepatocytes. J Biol Chem (1987) 0.89
Short-term and long-term effects of methamphetamine on biogenic amine metabolism in extra-striatal dopaminergic nuclei. Neuropharmacology (1980) 0.89
Catch up growth and pancreatic function in growth retarded neonates. Arch Dis Child Fetal Neonatal Ed (1995) 0.88
Polymorphonuclear leukocyte inhibition by therapeutic concentrations of theophylline is mediated by cyclic-3',5'-adenosine monophosphate. Am Rev Respir Dis (1988) 0.87
Brain-specific polypeptide 1B236 exists in multiple molecular forms. Proc Natl Acad Sci U S A (1985) 0.87
A rapid and reversible change in dopamine transporters induced by methamphetamine. Eur J Pharmacol (1997) 0.87
Dopamine D2 receptors exert tonic regulation over discrete neurotensin systems of the rat brain. Brain Res (1989) 0.87
Methamphetamine-induced depression of monoamine synthesis in the rat: development of tolerance. J Neurochem (1985) 0.87
Microdialysis assessment of methamphetamine-induced changes in extracellular neurotensin in the striatum and nucleus accumbens. J Pharmacol Exp Ther (1996) 0.87
Effects of 3,4-dihydroxymethamphetamine and 2,4,5-trihydroxymethamphetamine, two metabolites of 3,4-methylenedioxymethamphetamine, on central serotonergic and dopaminergic systems. J Pharmacol Exp Ther (1992) 0.86
Differential effects of antipsychotic and psychotomimetic drugs on neurotensin systems of discrete extrapyramidal and limbic regions. J Pharmacol Exp Ther (1994) 0.86
Methamphetamine-induced reduction in D1 and D2 dopamine receptors as evidenced by autoradiography: comparison with tyrosine hydroxylase activity. Neuroscience (1987) 0.86
Mechanisms for tolerance to methamphetamine effects. Neuropharmacology (1996) 0.85
Response by the neurotensin systems of the basal ganglia to cocaine treatment. Eur J Pharmacol (1989) 0.85
Species comparison of adenosine and beta-adrenoceptors in mammalian atrial and ventricular myocardium. Eur J Pharmacol (1993) 0.85
Long-term effects of methamphetamine on the synthesis and metabolism of 5-hydroxytryptamine in various regions of the rat brain. Neuropharmacology (1981) 0.84
The role of NMDA receptor systems in neuropeptide responses to stimulants of abuse. Drug Alcohol Depend (1995) 0.84
Changes in the limbic neurotensin systems induced by dopaminergic drugs. Eur J Pharmacol (1988) 0.83
Glucocorticoids and 3,4-methylenedioxymethamphetamine (MDMA)-induced neurotoxicity. Eur J Pharmacol (1989) 0.83
Methcathinone: an initial study of its effects on monoaminergic systems. J Pharmacol Exp Ther (1996) 0.83
Somatostatin-28(1-12)-like immunoreactivity in the rat. Endocrinology (1982) 0.83
Methamphetamine-induced rapid and reversible reduction in the activities of tryptophan hydroxylase and dopamine transporters: oxidative consequences? Ann N Y Acad Sci (1998) 0.83
Responses of limbic and extrapyramidal neurotensin systems to stimulants of abuse. Involvement of dopaminergic mechanisms. Ann N Y Acad Sci (1992) 0.83
Studies on the mechanism of tolerance to methamphetamine. Brain Res (1985) 0.82
Macrophages and liposomes in inflammatory disease: friends or foes? Int J Pharm (2011) 0.82
Influence of methamphetamine and neuroleptic drugs on tyrosine hydroxylase activity. Eur J Pharmacol (1974) 0.82
Production of antibodies to dopamine-beta-hydroxylase of bovine adrenal medulla. Mol Pharmacol (1967) 0.82
Synthesis of nucleotides in adrenal medulla and their uptake into chromaffin granules. Biochem Pharmacol (1976) 0.82
Effect of MK-801 on the decrease in tryptophan hydroxylase induced by methamphetamine and its methylenedioxy analog. Eur J Pharmacol (1989) 0.82
Acute inactivation of tryptophan hydroxylase by amphetamine analogs involves the oxidation of sulfhydryl sites. Eur J Pharmacol (1989) 0.82
Methamphetamine-induced changes in the striatal-nigral dynorphin system: role of D-1 and D-2 receptors. Eur J Pharmacol (1987) 0.82
Effects of a single dose of methamphetamine and iprindole on the serotonergic and dopaminergic system of the rat brain. J Pharmacol Exp Ther (1983) 0.82
The acute effects of methamphetamine, amphetamine and p-chloroamphetamine on the cortical serotonergic system of the rat brain: evidence for differences in the effects of methamphetamine and amphetamine. Eur J Pharmacol (1985) 0.82
Thoracic splenosis. Clin Nucl Med (1994) 0.81
Comparison of neurotensin responses to MDL 100,907, a selective 5HT2A antagonist, with clozapine and haloperidol. Brain Res Bull (1997) 0.81
The rCBF response to Diamox in normal subjects and cerebrovascular disease patients. J Neurosurg (1987) 0.81
Reciprocal modulation of tyrosine hydroxylasea activity in rat carotid body. Brain Res (1979) 0.81
Human relaxin increases cyclic AMP levels in cultured anterior pituitary cells. Biochem Biophys Res Commun (1987) 0.81
Dexamethasone-induced bradycardia. Lancet (1988) 0.81
Plasma zinc in psoriatic in-patients treated with local zinc applications. Br J Dermatol (1980) 0.81
The effect of hypothermic doses of 1-delta 9-tetrahydrocannabinol on biogenic amine metabolism in selected parts of the rat brain. Life Sci (1974) 0.81